17/08/2026
📝We are excited to share our latest study, which uncovers the pivotal role of small extracellular vesicle (sEV)-delivered nidogen 1 (NID1) in driving liver cancer progression and metastasis. Our research demonstrates that NID1-enriched sEVs enhance oncogenic behaviors in hepatocellular carcinoma (HCC) through activation of the TGM3-mediated YAP/TAZ signaling cascade, underscoring the sEV-NID1-TGM3 axis as a promising therapeutic target for HCC. Importantly, we show that targeting NID1 with a novel monoclonal antibody effectively suppresses tumor growth and metastasis in multiple HCC models.
https://isevjournals.onlinelibrary.wiley.com/doi/10.1002/jev2.70359